EntryPoint Capital LLC Acquires New Position in Celanese Corporation $CE

Key Points

• EntryPoint Capital LLC acquired a new position in Celanese Corporation, purchasing 6,088 shares valued at approximately $346,000 in the first quarter.
• Celanese reported $1.44 EPS for the last quarter, exceeding estimates, but noted a 4.5% decline in revenue year-over-year.
• Institutional investors own 98.87% of Celanese stock, reflecting strong interest from larger funds in the company.

EntryPoint Capital LLC purchased a new position in Celanese Corporation (NYSE:CE - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 6,088 shares of the basic materials company's stock, valued at approximately $346,000.

A number of other large investors have also added to or reduced their stakes in the stock. Turtle Creek Asset Management Inc. boosted its stake in Celanese by 266.7% in the fourth quarter. Turtle Creek Asset Management Inc. now owns 3,506,440 shares of the basic materials company's stock valued at $242,681,000 after acquiring an additional 2,550,334 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Celanese by 35.0% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,164,150 shares of the basic materials company's stock valued at $179,629,000 after purchasing an additional 819,489 shares during the last quarter. Federated Hermes Inc. grew its holdings in Celanese by 9,132.0% during the first quarter. Federated Hermes Inc. now owns 1,801,349 shares of the basic materials company's stock valued at $102,263,000 after purchasing an additional 1,781,837 shares during the period. Dimensional Fund Advisors LP increased its position in Celanese by 20.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,599,615 shares of the basic materials company's stock worth $110,704,000 after buying an additional 275,488 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Celanese by 891.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,521,564 shares of the basic materials company's stock valued at $105,308,000 after buying an additional 1,368,104 shares during the period. Hedge funds and other institutional investors own 98.87% of the company's stock.

Celanese Stock Performance

Shares of Celanese stock traded down $0.17 during midday trading on Wednesday, hitting $46.92. The company had a trading volume of 219,748 shares, compared to its average volume of 2,797,461. The stock has a market cap of $5.14 billion, a price-to-earnings ratio of -3.16, a PEG ratio of 2.05 and a beta of 1.10. The company has a quick ratio of 1.22, a current ratio of 2.05 and a debt-to-equity ratio of 2.22. The company has a fifty day simple moving average of $53.42 and a 200 day simple moving average of $52.46. Celanese Corporation has a 12-month low of $36.29 and a 12-month high of $142.54.

Celanese (NYSE:CE - Get Free Report) last posted its quarterly earnings results on Monday, August 11th. The basic materials company reported $1.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.38 by $0.06. The company had revenue of $2.53 billion during the quarter, compared to analyst estimates of $2.50 billion. Celanese had a negative net margin of 16.30% and a positive return on equity of 10.48%. Celanese's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period last year, the firm posted $2.38 EPS. Celanese has set its Q3 2025 guidance at 1.100-1.400 EPS. As a group, analysts predict that Celanese Corporation will post 8.79 earnings per share for the current fiscal year.

Celanese Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 11th. Investors of record on Tuesday, July 29th were paid a dividend of $0.03 per share. The ex-dividend date was Tuesday, July 29th. This represents a $0.12 annualized dividend and a yield of 0.3%. Celanese's payout ratio is presently -0.81%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CE. Zacks Research downgraded Celanese from a "hold" rating to a "strong sell" rating in a research note on Thursday, August 14th. Robert W. Baird cut their target price on shares of Celanese from $67.00 to $50.00 and set an "outperform" rating for the company in a research report on Wednesday, August 13th. JPMorgan Chase & Co. lowered their price target on shares of Celanese from $47.00 to $40.00 and set a "neutral" rating on the stock in a research report on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $52.00 price objective on shares of Celanese and gave the stock a "buy" rating in a report on Wednesday, August 13th. Finally, Cfra Research raised shares of Celanese to a "moderate sell" rating in a report on Tuesday, August 12th. Six investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Celanese currently has an average rating of "Hold" and a consensus target price of $59.39.

Celanese Company Profile

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.